|The UNC Center for Innovative Clinical Trials contracts and projects|
The University of North Carolina (UNC) at Chapel Hill established the Center for Innovative Clinical Trials (CICT) July 1, 2007. Clinical trials are controlled studies that test the relative benefits of various treatments, such as drugs, surgery, or interventions in human beings. The CICT is led by Dr. Joseph G. Ibrahim, Alumni Distinguished Professor of Biostatistics in the Department of Biostatistics and Director of the Biostatistics Core at the Lineberger Comprehensive Cancer Center (LCCC). The CICT has an interdisciplinary focus and theme, in which faculty from several departments at UNC and other institutions, as well as collaborators from industry engage in both methodologic and applied research in clinical trials design, analysis, and evaluation.
The main mission of the CICT is to develop, as well as integrate, methodologic and applied research for the design and analysis of clinical trials. By building on UNC's reputation and excellence in translational research, one of the primary goals of the CICT is to advance statistical science in clinical trials and quickly move it forward into clinical and statistical practice. One of the unique strengths of the CICT and UNC in general, is the ability to nicely balance methodological and collaborative research in clinical trials by building highly interdisciplinary and integrated research teams that are capable of producing new methodology and putting it into clinical and statistical practice. Our goal is to become globally recognized as the premier leader in research regarding all aspects of clinical trials.
|Last updated July 28, 2009|